ABT Abbott Laboratories

  1. Stocks
  2. Healthcare
  3. NYSE: ABT

Price (delayed)

$127.44

Market cap

$225.93B

P/E Ratio

35.7

Dividend/share

$1.71

EPS

$3.57

Enterprise value

$235.77B

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott ...

Highlights
Abbott Laboratories's net income has surged by 105% YoY and by 11% QoQ
The EPS has soared by 104% YoY and by 12% from the previous quarter
ABT's gross margin is down by 3.3% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: https://www.abbott.com
Peers: JNJ PFE TMO HOLX

Key stats

What are the main financial stats of ABT
Market
Shares outstanding
1.77B
Market cap
$225.93B
Enterprise value
$235.77B
Valuations
Price to earnings (P/E)
35.7
Price to book (P/B)
6.65
Price to sales (P/S)
5.64
EV/EBIT
30.44
EV/EBITDA
21
EV/Sales
5.86
Earnings
Revenue
$40.23B
EBIT
$7.75B
EBITDA
$11.23B
Free cash flow
$8.64B
Per share
EPS
$3.57
Free cash flow per share
$4.86
Book value per share
$19.15
Revenue per share
$22.61
TBVPS
$20.29
Balance sheet
Total assets
$73.27B
Total liabilities
$39.24B
Debt
$18.5B
Equity
$34.03B
Working capital
$10.01B
Liquidity
Debt to equity
0.54
Current ratio
1.79
Quick ratio
1.19
Net debt/EBITDA
0.88
Margins
EBITDA margin
27.9%
Gross margin
55.7%
Net margin
15.8%
Operating margin
18.5%
Efficiency
Return on assets
8.9%
Return on equity
19.3%
Return on invested capital
23%
Return on capital employed
12.8%
Return on sales
19.3%
Dividend
Dividend yield
1.34%
DPS
$1.71
Payout ratio
47.9%

ABT stock price

How has the Abbott Laboratories stock price performed over time
Intraday
-0.04%
1 week
-0.42%
1 month
2.23%
1 year
20.57%
YTD
16.39%
QTD
9.93%

Financial performance

How have Abbott Laboratories's revenue and profit performed over time
Revenue
$40.23B
Gross profit
$22.43B
Operating income
$7.43B
Net income
$6.38B
Gross margin
55.7%
Net margin
15.8%
Abbott Laboratories's net income has surged by 105% YoY and by 11% QoQ
The operating income has soared by 85% YoY and by 11% from the previous quarter
Abbott Laboratories's net margin has surged by 60% YoY and by 3.3% QoQ
Abbott Laboratories's operating margin has increased by 45% YoY and by 2.8% from the previous quarter

Growth

What is Abbott Laboratories's growth rate over time

Valuation

What is Abbott Laboratories stock price valuation
P/E
35.7
P/B
6.65
P/S
5.64
EV/EBIT
30.44
EV/EBITDA
21
EV/Sales
5.86
The EPS has soared by 104% YoY and by 12% from the previous quarter
ABT's P/E is 51% below its 5-year quarterly average of 72.9 and 16% below its last 4 quarters average of 42.7
ABT's price to book (P/B) is 58% higher than its 5-year quarterly average of 4.2 and 9% higher than its last 4 quarters average of 6.1
ABT's equity is up by 10% year-on-year
ABT's P/S is 31% above its 5-year quarterly average of 4.3
The revenue has grown by 28% YoY and by 8% from the previous quarter

Efficiency

How efficient is Abbott Laboratories business performance
Abbott Laboratories's return on assets has surged by 93% YoY and by 10% QoQ
ABT's ROE has soared by 93% YoY and by 9% from the previous quarter
The ROIC has soared by 80% YoY and by 12% from the previous quarter
The ROS has grown by 47% YoY and by 4.3% from the previous quarter

Dividends

What is ABT's dividend history
DPS
$1.71
Dividend yield
1.34%
Payout ratio
47.9%
Recent dividends

Financial health

How did Abbott Laboratories financials performed over time
The total assets is 87% more than the total liabilities
ABT's quick ratio is up by 28% year-on-year and by 2.6% since the previous quarter
The current ratio has increased by 14% YoY and by 2.3% QoQ
Abbott Laboratories's debt is 46% lower than its equity
Abbott Laboratories's debt to equity has decreased by 16% YoY
ABT's equity is up by 10% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.